These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 24074710

  • 21. [Study of xiaozhang recipe combined with lamivudine in treatment of 84 chronic viral hepatitis B patients with compensated liver cirrhosis].
    Zhou ZH, Li M, Huang LY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1220-3. PubMed ID: 22013800
    [Abstract] [Full Text] [Related]

  • 22. Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies.
    Huang C, Shen D, Sun S, Huang Y, Xin Y, Luo H, Chen Y, Zhou Z, Liu F, Chen X.
    Medicine (Baltimore); 2019 Apr; 98(17):e15297. PubMed ID: 31027094
    [Abstract] [Full Text] [Related]

  • 23. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L, Zhou Y, Peng X, Deng H, Deng Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [Abstract] [Full Text] [Related]

  • 24. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY, Li J, Zhang LF, Chen HY, Zhu LM, Wei L, Sun Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 08; 88(2):96-100. PubMed ID: 18353212
    [Abstract] [Full Text] [Related]

  • 25. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group.
    Gut; 2011 Aug 08; 60(8):1109-16. PubMed ID: 21270118
    [Abstract] [Full Text] [Related]

  • 26. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL, Netherlands Association of Gastroenterologists and Hepatologists.
    Neth J Med; 2008 Aug 08; 66(7):292-306. PubMed ID: 18663260
    [Abstract] [Full Text] [Related]

  • 27. The efficacy and safety of entecavir in patients with advanced schistosomiasis co-infected with hepatitis B virus.
    Huang LH, Qiu YW, Hua HY, Niu XH, Wu PF, Wu HY, Zhu HY, Yang XJ, Yao SZ, Li YG.
    Int J Infect Dis; 2013 Aug 08; 17(8):e606-9. PubMed ID: 23490092
    [Abstract] [Full Text] [Related]

  • 28. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
    Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL.
    Gastroenterology; 2010 Aug 08; 139(2):491-8. PubMed ID: 20381492
    [Abstract] [Full Text] [Related]

  • 29. [Experimental study on effect of dahuang zhechong wan combined with adefovir dipivoxil in preventing hepatic fibrosis in patients with chronic hepatitis B].
    Zhang L, Chang Y.
    Zhongguo Zhong Yao Za Zhi; 2012 Mar 08; 37(6):862-4. PubMed ID: 22715739
    [Abstract] [Full Text] [Related]

  • 30. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
    Ji FZ, Wang L, Yang BH, Zhao JJ, Liu F, Xue Y, Li T.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr 08; 20(4):280-4. PubMed ID: 22964149
    [Abstract] [Full Text] [Related]

  • 31. Effects of da ding feng zhu decoction in 30 cases of liver fibrosis.
    Li W, Wang C, Zhang J.
    J Tradit Chin Med; 2003 Dec 08; 23(4):251-4. PubMed ID: 14719288
    [Abstract] [Full Text] [Related]

  • 32. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
    Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D.
    Acta Clin Croat; 2010 Sep 08; 49(3):257-65. PubMed ID: 21462814
    [Abstract] [Full Text] [Related]

  • 33. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK, Seto WK, Fung J, Ip P, Huang FY, Lai CL, Yuen MF.
    Clin Gastroenterol Hepatol; 2013 Aug 08; 11(8):1004-10.e1. PubMed ID: 23376799
    [Abstract] [Full Text] [Related]

  • 34. [Clinical observation on the safety and efficacy of ursodeoxycholic acid and fuzheng huayu capsule in the treatment of primary biliary cirrhosis].
    Wu Y, Yao DK, Zhu L.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov 08; 32(11):1477-82. PubMed ID: 23359968
    [Abstract] [Full Text] [Related]

  • 35. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun 08; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]

  • 36. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
    Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, Manesis E, Hadziyannis SJ.
    Hepatology; 2005 Jul 08; 42(1):121-9. PubMed ID: 15962291
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
    Güzelbulut F, Ovünç AO, Oetinkaya ZA, Senates E, Gökden Y, Saltürk AG, Sezikli M, Ozkara S, Cetinkaya F.
    Hepatogastroenterology; 2012 Jul 08; 59(114):477-80. PubMed ID: 21940383
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses.
    Meng N, Gao X, Yan W, Wang M, Liu P, Lu XD, Zhang SJ, Lu YQ, Tang WX.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Apr 08; 35(2):230-234. PubMed ID: 25877357
    [Abstract] [Full Text] [Related]

  • 39. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
    Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Safadi R, Lee SS, Halota W, Goodman Z, Chi YC, Zhang H, Hindes R, Iloeje U, Beebe S, Kreter B.
    Hepatology; 2010 Sep 08; 52(3):886-93. PubMed ID: 20683932
    [Abstract] [Full Text] [Related]

  • 40. Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue.
    Jang W, Yu SI, Sinn DH, Park SH, Park H, Park JY, Jeon TJ, Oh TH, Shin WC, Choi WC.
    Clin Res Hepatol Gastroenterol; 2014 Apr 08; 38(2):195-200. PubMed ID: 24231289
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.